Tuberculosis Research and Epidemiology

Работ: 149

1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

   Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

   СтатьяTuberculosis Research and EpidemiologyEurosurveillance2013Цитирований: 15

   ABIABI:AkademIndex/openalex/2026.other.163910

2. Multidrug-resistant Tuberculosis in Central Asia

   Helen Cox, Juan Daniel Orozco, Roy Male +6

   СтатьяTuberculosis Research and EpidemiologyEmerging infectious diseases2004Цитирований: 6

   ABIABI:AkademIndex/openalex/2026.other.020023

3. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

   Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

   СтатьяTuberculosis Research and EpidemiologyNew England Journal of Medicine2022Цитирований: 5

   ABIABI:AkademIndex/openalex/2022.article.000002

4. Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study

   Jamshid Gadoev, Damin Asadov, Mirzagolib Tillashaykhov +14

   СтатьяTuberculosis Research and EpidemiologyPLoS ONE2015Цитирований: 4

   ABIABI:AkademIndex/openalex/2015.article.000023

5. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   Shona Horter, Beverley Stringer, Jane Greig +5

   СтатьяTuberculosis Research and EpidemiologyBMC Infectious Diseases2016Цитирований: 4

   ABIABI:AkademIndex/openalex/2016.article.000054

6. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Обзорная статьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2017Цитирований: 4

   ABIABI:AkademIndex/openalex/2017.review-article.000004

7. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   James M. Trauer, Jay Achar, Nargiza Parpieva +7

   СтатьяTuberculosis Research and EpidemiologyBMC Medicine2016Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.195695

8. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

   Shona Horter, Beverley Stringer, Nell Gray +5

   СтатьяTuberculosis Research and EpidemiologyBMC Infectious Diseases2020Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.195708

9. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan

   Parvati Nair, T. Hasan, K. K. Zaw +9

   СтатьяTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease2022Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.281624

10. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan

    Beverley Stringer, Karen Lowton, Mirzagaleb N. Tillashaikhov +5

    СтатьяTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease2016Цитирований: 2

    ABIABI:AkademIndex/openalex/2016.article.000087

11. Health system support and health system strengthening: two key facilitators to the implementation of ambulatory tuberculosis treatment in Uzbekistan

    Stefan Köhler, Damin Asadov, Andreas Bründer +4

    СтатьяTuberculosis Research and EpidemiologyHealth Economics Review2016Цитирований: 2

    ABIABI:AkademIndex/openalex/2016.article.000128

12. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

    Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

    СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 2

    ABIABI:AkademIndex/openalex/2021.article.000207

13. Antituberculosis Activity and Pharmacokinetics of Polymer Conjugates of Isoniazid and Ethambutol

    Ш. А. Шомуротов, Oliy Ravshanovich Akhmedov, А. С. Тураев +1

    СтатьяInfectious Diseases and TuberculosisPharmaceutical Chemistry Journal2021Цитирований: 2

    ABIABI:AkademIndex/openalex/2021.article.001447

14. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

    Sharofiddin Yuldashev, Nargiza Parpieva, Salikhdjan Alimov +6

    СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.262609

15. Ambulatory tuberculosis treatment in post-Semashko health care systems needs supportive financing mechanisms

    Stefan Köhler, Damin Asadov, Andreas Bründer +4

    СтатьяHIV/AIDS Impact and ResponsesThe International Journal of Tuberculosis and Lung Disease2014Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.364601

16. The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia

    Helen Cox, Tanja Kubica, Daribay Doshetov +3

    СтатьяTuberculosis Research and EpidemiologyRespiratory Research2005Цитирований: 1

    ABIABI:AkademIndex/openalex/2005.article.000006

17. Tuberculosis Recurrence and Mortality after Successful Treatment: Impact of Drug Resistance

    Helen Cox, Yared Kebede, Sholpan Allamuratova +8

    СтатьяTuberculosis Research and EpidemiologyPLoS Medicine2006Цитирований: 1

    ABIABI:AkademIndex/openalex/2006.article.000008

18. Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study

    Tatiana Belkina, Doniyor S Khojiev, Mirzagaleb Tillyashaykhov +4

    СтатьяTuberculosis Research and EpidemiologyBMC Infectious Diseases2014Цитирований: 1

    ABIABI:AkademIndex/openalex/2014.article.000040

19. Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?

    Mathieu Bastard, Maryline Bonnet, Philipp du Cros +9

    ДругоеTuberculosis Research and EpidemiologyAmerican Journal of Respiratory and Critical Care Medicine2015Цитирований: 1

    ABIABI:AkademIndex/openalex/2015.other.000002

20. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

    СтатьяTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease2018Цитирований: 1

    ABIABI:AkademIndex/openalex/2018.article.000181

21. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    S.K. Abidi, Jay Achar, M.M. Assao Neino +34

    СтатьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2019Цитирований: 1

    ABIABI:AkademIndex/openalex/2019.article.000020

22. Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia

    A. Engström, Uladzimir Antonenka, Abdylat Kadyrov +10

    СтатьяTuberculosis Research and EpidemiologyBMC Infectious Diseases2019Цитирований: 1

    ABIABI:AkademIndex/openalex/2019.article.000129

23. The study of life quality parameters in children and adolescents with HIV associated tuberculosis

    Динара Намазовна Аджаблаева

    СтатьяTuberculosis Research and EpidemiologyTuberculosis and lung diseases2020Цитирований: 1

    ABIABI:AkademIndex/openalex/2020.article.000868

24. Prevention Of Anemia In Patients With Tuberculosis

    Mamatkulova Feruza Xaydarovna, Mamatova Nargiza Toirjonovna, Ruziboeva Oyjamol Narzullaevna

    СтатьяTuberculosis Research and EpidemiologyThe American Journal of Medical Sciences and Pharmaceutical Research2020Цитирований: 1

    ABIABI:AkademIndex/openalex/2020.article.000973

25. Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, Uzbekistan

    Jamshid Gadoev, Damin Asadov, Anthony Harries +11

    СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 1

    ABIABI:AkademIndex/openalex/2021.article.000489